Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases

Cancer
S M GapsturD P Winchester

Abstract

It has been postulated that different biologic characteristics of a tumor might account for at least a portion of the disparity in breast cancer survival for patients across racial and ethnic groups. The hormone receptor status of breast tumors is one characteristic with prognostic significance. Results of several studies indicate a higher proportion of estrogen receptor negative (ER-) breast tumors among black or Hispanic women compared with non-Hispanic whites. We investigated whether the association between race and ethnicity and the joint combination of ER and progesterone receptor (PR) status was independent of age and other tumor characteristics at diagnosis. Relevant data were obtained from 13,239 breast cancer cases identified as part of the 1990 Patient Care Evaluation Study of Breast Cancer. In univariate analysis, the proportions of ER+PR+, ER+PR-, ER-PR+, and ER-PR- tumors among non-Hispanics whites were 59%, 15%, 6%, and 20%, respectively; among Hispanics the proportions were 58%, 12%, 8%, and 22%, respectively; and among blacks the proportions were 44%, 14%, 7%, and 35%, respectively. After controlling for age, tumor size, and histology, using polychotomous logistic regression, these was no difference in hormone-r...Continue Reading

References

Mar 15, 1992·American Journal of Epidemiology·N H GordonN A Berger
Jun 1, 1992·British Journal of Cancer·J L RichardsonR K Ross
May 1, 1991·The British Journal of Surgery·Z Rayter
Feb 1, 1987·American Journal of Epidemiology·J L StanfordR N Hoover
Mar 1, 1987·American Journal of Public Health·L N BeverlyS J Soong
Feb 1, 1984·Cancer·J L Wittliff
May 1, 1984·American Journal of Epidemiology·B S HulkaK S McCarty
Aug 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A TavaniS Salvini
May 4, 1994·Journal of the National Cancer Institute·R M ElledgeC K Osborne
Nov 24, 1993·JAMA : the Journal of the American Medical Association·P D SorlieE Rogot
Apr 1, 1994·International Journal of Epidemiology·M EidsonJ M Samet

❮ Previous
Next ❯

Citations

Dec 18, 2013·Cancer Causes & Control : CCC·Julie R PalmerAndrew F Olshan
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Jason Chia-Hsien ChengAndrew T Huang
Jun 12, 2009·Journal of Women's Health·Linda Vona-Davis, David P Rose
Feb 24, 2001·American Journal of Public Health·A M Marbella, P M Layde
Jul 1, 2005·Journal of General Internal Medicine·Jeanne S MandelblattUNKNOWN Breast Cancer in Older Women Research Consortium
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Swann Arp AdamsWei Zheng
Jan 24, 2007·Breast Cancer Research : BCR·Lisa K DunnwaldChristopher I Li
Feb 4, 2009·Journal of General Internal Medicine·Mitchell D WongMartin F Shapiro
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lynn RosenbergJulie R Palmer
Mar 26, 2011·Journal of the National Cancer Institute·James V TricoliBrandon Hayes-Lattin
May 24, 2011·Breast Cancer Research and Treatment·Veronica I Lagos-JaramilloJeffrey N Weitzel
Aug 19, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie R PalmerLynn Rosenberg
Jul 8, 2009·Pakistan Journal of Biological Sciences : PJBS·W K B A OwireduN Amidu
Nov 29, 2015·Journal of the National Cancer Institute·Lynn RosenbergJulie R Palmer
Jun 1, 1997·American Journal of Obstetrics and Gynecology·J OchiengK N Johnson
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher I LiKathleen E Malone
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J GriggsSteven J Katz
Jun 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeanne S MandelblattMarianne Fahs
May 27, 2017·Breast Cancer Research and Treatment·M E RoselandMichael S Simon
Jun 26, 2008·British Journal of Cancer·A GakwayaD Kanyike
Jun 27, 2002·Breast Cancer Research and Treatment·Sue A Joslyn
Jul 31, 2007·Breast Cancer Research and Treatment·Mary Jo LundJ William Eley
Jun 27, 2006·Pathology Oncology Research : POR·Maher A SughayerMahmoud Al-Masri
Aug 26, 2009·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Ping TangDavid G Hicks
Nov 10, 2009·Annals of Surgical Oncology·Erin F GillespieJennifer J Griggs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.